Company Operations - As of March 30, 2025, the company operates 74 permanent retail stores and eight manufacturing facilities, with a global leased property footprint including a distribution center in the United States[249]. - The company’s manufacturing and warehouse properties range in size from 50,000 to 190,000 square feet, indicating a significant operational capacity[249]. Financial Reporting - The company’s fiscal year 2025 is a 52-week reporting cycle ending on March 30, 2025, with previous fiscal years ending on April 2, 2023, and March 31, 2024[14]. - The company’s consolidated financial statements are prepared in accordance with IFRS Accounting Standards, with all monetary amounts reported in Canadian dollars[13]. Regulatory Compliance - The company is subject to various government regulations, including labor laws, advertising laws, and consumer protection regulations, which it believes to be in material compliance with[245]. - The company emphasizes the importance of monitoring changes in laws and regulations affecting its operations, particularly regarding tariffs and trade agreements for products sold outside Canada[245]. Market Adaptation - The company maintains a focus on adapting to changing consumer preferences and managing inventory levels to fulfill demand[22]. - The company faces risks related to global supply chain disruptions, which could impact its ability to maintain sufficient inventory levels[22]. - The company is committed to expanding its brand and product offerings, although it acknowledges potential challenges in maintaining brand strength and entering new markets[23]. Organizational Structure - The company’s organizational structure reflects its various entities as of May 19, 2025, indicating a well-defined management hierarchy[246].

Interim Financial Information Flex LNG Ltd. First Quarter 2025 May 21, 2025 May 21, 2025 - Hamilton, Bermuda Flex LNG Ltd. ("we", "us", "our", "Flex LNG", or the "Company") today announced its unaudited financial results for the three months ended March 31, 2025. Highlights: A summary of our financial highlights for the quarter are below: | | Q1 2025 | Q4 2024 | | --- | --- | --- | | 1 Vessel operating revenues | $88.4m | $90.9m | | Net income | $18.7m | $45.2m | | Earnings per share (basic) | $0.35 | $0.84 ...

Financial Performance - Total revenue for the three months ended March 31, 2025, was $223,849, a decrease of 13.7% compared to $259,319 in the same period of 2024[18]. - Gross profit for Q1 2025 was $61,381, down 65% from $175,532 in Q1 2024[18]. - Operating expenses decreased to $3,541,363 in Q1 2025 from $5,770,361 in Q1 2024, representing a reduction of 38.5%[18]. - Net loss attributable to Lottery.com Inc. for Q1 2025 was $3,306,468, compared to a net loss of $5,594,337 in Q1 2024, indicating an improvement of 41.5%[18]. - The company reported a comprehensive loss of $3,323,740 for Q1 2025, compared to a comprehensive loss of $5,651,658 in Q1 2024[18]. Cash and Assets - Cash and restricted cash at the end of Q1 2025 totaled $468,677, significantly up from $68,035 at the beginning of the year[23]. - Total assets increased to $53,439,131 as of March 31, 2025, compared to $52,942,271 as of December 31, 2024[17]. - Total current liabilities rose to $31,532,777 in Q1 2025 from $30,397,442 in Q4 2024, an increase of 3.7%[17]. - The Company reported an accumulated deficit of approximately $266.8 million and negative working capital of approximately $15.0 million as of March 31, 2025[36]. Strategic Operations - The company moved its headquarters to Fort Worth, Texas, in September 2024, indicating a strategic shift in operations[25]. - The Company completed the acquisition of Spektrum Ltd for $1.5 million in common stock at $3 per share, supporting its strategic expansion and development of Lottery.com International[32]. - The Company resumed ticket sales operations on a limited basis on April 25, 2023, to support its affiliate partners through its Texas retail network[30]. - The Company launched the Sports.com app in 2024, providing users worldwide with access to curated sports content[31]. - The Company has made significant efforts to resume core lottery and gaming operations and expand the Sports.com brand globally, as evidenced by recent investment commitments[167]. Compliance and Governance - The company received a letter from Nasdaq indicating it did not meet the minimum requirement of $5 million in Market Value of Publicly Held Shares but was granted a 180-day grace period to regain compliance[178]. - The company successfully regained compliance with Nasdaq listing requirements on April 10, 2024, after its Market Value of Publicly Held Shares closed at $5 million or more for ten consecutive business days[179]. - The company has appointed Mr. Marc Bircham as an Executive Director to its Board of Directors on May 13, 2025[164]. Acquisitions and Market Expansion - The Company acquired Global Gaming in June 2021, which holds 80% equity in Aganar and JuegaLotto, expanding its operations in the Latin American lottery market[201]. - The estimated size of the Latin American lottery market is $0.68 billion, with a projected compound annual growth rate of 6.05% through 2028[202]. - The Company acquired TinBu, LLC, a digital publisher providing lottery data results, enhancing its Data Service to deliver daily results for over 800 lottery games from more than 40 countries[208]. - The company is acquiring Nook Holdings Limited for approximately $2.314 million, with plans to close the transaction in Q2 2025[212]. - Nook has procured 200 licenses in the sports, health, and wellness sector, providing services to entrepreneurs in the Middle Eastern market[212]. Financial Obligations and Funding - The company has outstanding payroll obligations of approximately $4.08 million as of March 31, 2025, which remain unpaid following operational cessation[171]. - A loan of $67,941 was provided by the Chief Financial Officer at zero percent interest, which was repaid in full through the issuance of common stock in February 2025[160]. - The Company entered into a loan agreement with Woodford Eurasia for up to $52.5 million, with $798,351 received by December 31, 2023, accruing interest at 12% per annum[185]. - The Woodford Loan Agreement allows for conversion into shares at a price of $5.60 per share, subject to a 4.99% ownership limitation[186]. Stock and Securities - The Company completed a reverse stock split of 1-for-20 on August 9, 2023, affecting all issued and outstanding shares[200]. - The company issued 8,373,205 shares of common stock during the quarter ended March 31, 2025, including 78,574 shares from the conversion of notes[13]. - The company had 3,101,277 restricted stock shares granted and vested at a fair value of $1.40 per share as of March 31, 2025[150]. - The company had 1,011,737 shares available for grant under stock options as of March 31, 2025, with an average exercise price of $2.00[147]. Operational Challenges - The company has experienced recurring net losses and negative cash flows from operations, raising substantial doubt about its ability to continue as a going concern[36]. - The company has faced operational challenges due to an internal investigation revealing non-compliance with laws and issues with internal accounting controls, leading to a cessation of operations in July 2022[168]. Revenue Recognition and Accounting - The Company recognizes revenues from lottery game sales at the time the digital representation is delivered, with no variable consideration involved[62]. - Deferred revenue is recorded when cash payments are received or due in advance of any performance, with payment terms varying by customer type[67]. - The Company uses the Black-Scholes option-pricing model to calculate the fair value of stock options and warrants[82]. - The Company accounts for lease and non-lease components as a single lease component under the available practical expedient[58].

Financial Performance - Contract revenues for Q1 fiscal 2026 increased by 10.2% to $1.259 billion compared to $1.142 billion in Q1 fiscal 2025[3] - Non-GAAP Adjusted EBITDA rose to $150.4 million, representing 11.9% of contract revenues, up from $130.9 million or 11.5% in the prior year[4] - Net income for the quarter was $61.0 million, or $2.09 per diluted share, compared to $62.6 million, or $2.12 per diluted share, in the previous year[4] - Organic contract revenues increased by 0.7% after excluding revenues from acquired businesses[3] Outlook - For fiscal 2026, the company increased its contract revenue outlook to a range of $5.290 billion to $5.425 billion, reflecting a growth of 12.5% to 15.4% over the prior year[6] - The second quarter fiscal 2026 outlook anticipates contract revenues between $1.38 billion and $1.43 billion[9] - Fiscal 2026 will include 53 weeks of operations, with the extra week occurring in the fourth quarter[7] Backlog and Share Repurchase - The company reported a record backlog of $8.127 billion as of April 26, 2025[8] - The company repurchased 200,000 shares for $30.2 million at an average price of $150.93 per share during Q1[5] Tax Benefits - The company experienced income tax benefits of $2.2 million from share-based awards during the quarter[4] - The provision for income taxes included tax benefits of $2.2 million and $5.9 million for the quarters ended April 26, 2025, and April 27, 2024, respectively, due to the vesting and exercise of share-based awards[27] Non-GAAP Measures - The Company reported Non-GAAP Organic Contract Revenues, which are contract revenues from businesses included for the entirety of both the current and prior year periods, excluding certain non-recurring items[26] - Non-GAAP Adjusted EBITDA for the quarter ended April 26, 2025, included stock-based compensation expense of $9.1 million, compared to $7.8 million for the quarter ended April 27, 2024[27]

Financial Performance - First quarter 2025 GAAP earnings per share (EPS) was $2.27, up from $2.03 in 2024, while adjusted EPS was $1.30[3]. - Net sales for the first quarter were $23.8 billion, a decrease of 2.8% compared to $24.5 billion in 2024[4]. - Comparable sales decreased by 3.8%, with a 5.7% decline in comparable store sales and a 4.7% increase in comparable digital sales[7]. - First quarter operating income was $1.5 billion, reflecting a 13.6% increase from the previous year[7]. - The first quarter gross margin rate was 28.2%, down from 28.8% in 2024, due to higher markdown rates and increased digital fulfillment costs[9]. - Adjusted diluted earnings per share (EPS) for the three months ended May 3, 2025, was $1.30, a decrease of 35.9% compared to $2.03 for the same period in 2024[30]. - Net earnings for the three months ended May 3, 2025, were $1,036 million, reflecting a 10.0% increase from $942 million for the same period in 2024[31]. - EBIT for the three months ended May 3, 2025, was $1,498 million, an increase of 13.0% compared to $1,325 million for the same period in 2024[31]. - After-tax return on invested capital (ROIC) for the trailing twelve months ended May 3, 2025, was 15.1%, down from 15.4% for the same period in 2024[34]. Sales and Guidance - The company expects a low-single digit decline in sales for fiscal 2025, with GAAP EPS guidance of $8.00 to $10.00 and adjusted EPS of approximately $7.00 to $9.00[6]. - The company provided full-year 2025 GAAP diluted EPS guidance of approximately $8.00 to $10.00, with adjusted diluted EPS guidance of $7.00 to $9.00[30]. - Net sales for the three months ended May 3, 2025, were $23,846 million, a decrease of 2.8% compared to $24,531 million for the same period in 2024[23]. - Comparable sales decreased by 3.8% for the three months ended May 3, 2025, compared to a decrease of 3.7% for the same period in 2024[27]. - Digitally originated comparable sales increased by 4.7% for the three months ended May 3, 2025, compared to an increase of 1.4% for the same period in 2024[27]. Shareholder Returns - Target paid dividends of $510 million in the first quarter, a 1.8% increase from $508 million in the previous year[11]. - The company repurchased $251 million of its shares, retiring 2.2 million shares at an average price of $114.60[12]. Strategic Initiatives - The company established a multi-year acceleration office to enhance decision-making speed and support growth initiatives[5]. - Digital comparable sales growth was driven by a 36% increase in same-day delivery through Target Circle 360[5].

Financial Performance - Q4 revenue reached $8.9 billion, a 3.9% increase as reported and 5.4% organic growth[3] - Q4 GAAP diluted EPS was $0.82, up 67%, while non-GAAP diluted EPS increased 11% to $1.62[3] - FY25 revenue totaled $33.5 billion, reflecting a 3.6% increase as reported and 4.9% organic growth[5] - FY25 GAAP diluted EPS rose 31% to $3.61, with non-GAAP diluted EPS increasing 6% to $5.49[8] - The company reported a total revenue of $33,537 million for FY25, a 3.6% increase from $32,364 million in FY24[44] - Net income for Q4 FY25 was $1,061 million, up from $659 million in Q4 FY24, marking a significant increase[58] - Basic earnings per share for Q4 FY25 were $0.82, compared to $0.49 in Q4 FY24, indicating strong earnings growth[58] - For the fiscal year ended April 25, 2025, total net sales reached $33,537 million, a 3.61% increase from $32,364 million in the previous fiscal year[69] - The diluted EPS for the fiscal year was $5.49, compared to $5.20 in the previous year, marking a 5.58% increase[69] Segment Performance - The Cardiovascular Portfolio generated FY25 revenue of $12.481 billion, a 5.5% increase as reported and 6.3% organic growth[14] - Cardiovascular segment revenue increased by 6.6% to $3,336 million in the fourth quarter of FY25, with organic growth of 7.8%[44] - Cardiac Rhythm & Heart Failure segment saw a revenue increase of 9.2% to $1,733 million in the fourth quarter, with organic growth of 10.3%[44] - Diabetes segment revenue grew by 10.4% to $728 million in the fourth quarter, with organic growth of 12.0%[44] - Neuroscience segment revenue increased by 2.9% to $2,620 million in the fourth quarter, with organic growth of 3.7%[44] - Cardiovascular segment revenue for FY25 reached $5,804 million, with an organic growth of 3.7% from FY24's $5,597 million[49] - Neuroscience segment reported revenue of $6,713 million for FY25, reflecting a 6.5% increase from FY24's $6,305 million[49] - Diabetes segment revenue grew by 8.3% in FY25, totaling $923 million compared to $852 million in FY24[49] Cash Flow and Shareholder Returns - Q4 cash from operations was $7.0 billion, with free cash flow of $5.2 billion[5] - The company returned $6.3 billion to shareholders in FY25, marking the 48th consecutive year of dividend increases[5] - The company reported a free cash flow of $5,185 million for the fiscal year 2025, slightly down from $5,200 million in 2024[85] Future Guidance - FY26 organic revenue growth is projected at approximately 5%, with reported growth expected between 4.8% and 5.1%[26] - FY26 diluted non-GAAP EPS is guided to be in the range of $5.50 to $5.60, considering potential tariff impacts[28] - The company plans to report its FY26 quarterly results on August 19, November 18, February 17, and May 20, 2026[31] - The company plans to separate its Diabetes business into a standalone public company within 18 months[21] Operational Insights - Medtronic's management emphasizes the importance of non-GAAP financial measures for understanding operational performance and trends[38] - Forward-looking statements indicate potential risks related to competitive factors and economic conditions that may impact future performance[35] - Research and development expenses for FY25 were $2,732 million, slightly down from $2,735 million in FY24[58] Balance Sheet Highlights - Cash and cash equivalents increased to $2,218 million as of April 25, 2025, compared to $1,284 million a year earlier[89] - Total assets rose to $91,680 million as of April 25, 2025, up from $89,981 million on April 26, 2024[89] - Current liabilities increased to $12,879 million from $10,789 million year-over-year[89] - Long-term debt increased to $25,642 million from $23,932 million in the previous year[89] - The company experienced a net income of $4,691 million for the fiscal year 2025, compared to $3,705 million in 2024[91] - The company recognized $151 million of accelerated amortization on certain intangible assets related to product line exits within the Cardiovascular Segment[70]

Financial Performance - Net revenues for fiscal 2025 increased by 4.0% to $1,360,824, compared to $1,309,055 in fiscal 2024 [230]. - Operating income rose by 34.5% to $221,817 in fiscal 2025, driven by operating leverage and a gain from the sale of a manufacturing facility [232]. - Gross profit increased by 8.3% to $748,958, representing 55.0% of net revenues in fiscal 2025, up from 52.8% in fiscal 2024 [242]. - Hospital revenue surged by 23.7% to $564,269, primarily due to growth in Interventional Technologies and Blood Management Technologies [241]. - Plasma revenue decreased by 6.0% to $535,431, primarily due to lower sales volumes in North America [239]. - Blood Center revenue fell by 7.8% to $261,124, driven by declines in the Whole Blood business [240]. - Research and development expenses increased by 15.2% to $62,722, reflecting increased headcount from recent acquisitions [243]. - Interest and other expenses decreased by 25.1% to $(9,746), primarily due to gains on extinguishment of convertible notes [250]. - The reported income tax rate decreased to 20.9% in fiscal 2025 from 22.6% in fiscal 2024 [251]. - For the year ended March 29, 2025, the company recorded a pre-tax income of $212.1 million and an income tax expense of $44.4 million, resulting in a reported tax rate of 20.9% [253]. Cash Flow and Financing Activities - As of March 29, 2025, the company had $306.8 million in cash and cash equivalents, an increase from $178.8 million as of March 30, 2024 [254][255]. - Net cash provided by operating activities was $181.7 million during fiscal 2025, relatively flat compared to fiscal 2024 [265]. - Net cash used in investing activities was $161.9 million during fiscal 2025, an increase of $160.5 million compared to fiscal 2024 [266]. - Net cash provided by financing activities was $108.8 million during fiscal 2025, an increase of $70.7 million compared to fiscal 2024 [267]. - The company authorized a share repurchase program of up to $500 million to offset the dilutive impact of employee equity grants [262]. - The company repurchased $150.0 million of common stock through an ASR with Goldman Sachs, completing the ASR in April 2025, and has fully funded a $300.0 million Share Repurchase Authorization [205]. Acquisitions and Divestitures - The company completed the divestiture of its Whole Blood product line for total cash consideration of up to $65.8 million, including $43.3 million upfront and up to $22.5 million in contingent consideration based on sales growth over the next three years [204]. - The acquisition of Attune Medical was completed for total consideration of $187.7 million, enhancing the Hospital business unit's presence in electrophysiology [210][211]. - The acquisition of OpSens was finalized for approximately $254.5 million, expanding the Hospital business unit portfolio in interventional cardiology [212][213]. - The company completed the acquisition of Attune Medical for a purchase price of $187.7 million, including contingent consideration with an initial fair value of $25.3 million [300]. - The fair value of identified intangible assets from the acquisition totaled $105.8 million, primarily consisting of developed technology [301]. Market and Operational Insights - The company has seen declining transfusion rates in mature markets due to minimally invasive procedures, impacting growth in the Blood Center market [218]. - The Vascular Closure market continues to grow with the launch of VASCADE MVP in Japan and CE mark clearance for VASCADE systems in fiscal 2023 [221]. - Advanced hemostasis testing is increasingly utilized in clinical decision-making, with TEG systems achieving high market penetration in North America and Europe [224][226]. - The company expanded its market presence in the U.K. with SafeTraceTX, addressing operational efficiency and cybersecurity needs [229]. - Approximately 42% of the company's revenue during fiscal 2025 was generated by its ten largest customers, indicating a concentration of credit risk [269]. - 25.7% of the company's sales in fiscal 2025 were generated outside the U.S., primarily in foreign currencies, with significant exposure to Japanese Yen, Euro, and Chinese Yuan [273]. Debt and Financial Instruments - As of March 29, 2025, total outstanding debt under the senior unsecured term loan was $245.3 million with an effective interest rate of 5.7% [293]. - The company has scheduled principal payments of $6.3 million during fiscal 2026 related to its term loan [261]. - The company utilizes interest rate swaps to convert variable rate borrowings to fixed rates, with a notional amount of $204.5 million as of March 29, 2025 [293]. - A 10% strengthening of the U.S. Dollar would result in a $5.6 million increase in the fair value of forward contracts, while a 10% weakening would lead to a $6.8 million decrease [292]. - The company has a program to mitigate foreign currency exchange rate exposure using derivative financial instruments, including forward foreign currency contracts [275]. Accounting and Valuation - The consolidated financial statements present fairly the financial position of the company as of March 29, 2025, in conformity with U.S. generally accepted accounting principles [295]. - The fair value of contingent consideration in business combinations is recorded at fair value and remeasured at each reporting period based on changes in underlying assumptions [289]. - The company reviews intangible assets for impairment at least annually, considering factors such as market size declines and increased competition [282]. - The income tax provision process involves assessing temporary differences and maintaining a valuation allowance for deferred tax assets that are not more-likely-than-not realizable [285]. - Sensitivity analyses were performed to evaluate changes in fair value resulting from changes in significant assumptions [303].

Exhibit 99.1 ZTO Reports First Quarter 2025 Unaudited Financial Results Parcels Volume Increased 19.1% to 8.5 Billion Adjusted Net Income Grew 1.6% to RMB2.3 Billion Annual Volume Guidance Reiterated to Grow 20%-24% SHANGHAI, May 21, 2025/PRNewswire/ - ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast- growing express delivery company in China ("ZTO" or the "Company"), today announced its unaudited financial results for the first quarter ended March 31, 2025. The Company grew parcel v ...

Financial Performance - Q4'25 revenue was $2.1 billion, down 5% year-over-year, with adjusted operating income of $22 million, exceeding guidance[12] - Q4 2025 revenue decreased by 5% to $2,143.8 million compared to $2,247.3 million in Q4 2024[35] - Total segment revenues decreased by 4% year-over-year to $9.505 billion, with the Outdoor segment showing a slight increase of 1% to $5.576 billion, while the Active segment declined by 12% to $3.095 billion[49] - Global revenue decreased by 5% in Q4 2025 and 4% for the full year, with constant currency changes of (3%) and (4%) respectively[94] - The company reported a net loss of $189.716 million for the twelve months ended March 2025, a significant improvement from a net loss of $968.882 million in the previous year[45] - Net loss for Q4 2025 was $150.8 million, compared to a net loss of $418.3 million in Q4 2024[39] - Total operating loss for Q4 2025 was $72.9 million, an improvement from a loss of $373.4 million in Q4 2024[39] - Adjusted operating income for the twelve months ended March 2025 was reported at $556.1 million, while GAAP operating income was $303.8 million[75] Brand Performance - The North Face® and Timberland® brands showed growth, while Vans® and Dickies® experienced declines, with Vans® down 22% year-over-year[14] - The North Face® brand revenue increased by 2% to $834.5 million, while Vans® brand revenue decreased by 22% to $492.6 million in Q4 2025[35] - Revenue growth for The North Face® in the APAC region was 12% for the three months ended March 2025, while Vans® experienced a decline of 25% in the same period[92] Cost Management and Savings - The company achieved $300 million in gross cost savings in FY'25, targeting $500 to $600 million in net operating income expansion in the medium term[13] - Cash dividends of $35 million were paid during the quarter, reflecting the company's commitment to returning value to shareholders[27] - VF incurred approximately $200.0 million in restructuring charges related to the Reinvent transformation program, with cumulative charges through Q4 of Fiscal 2025 totaling approximately $190.1 million[67] Debt and Cash Flow - Net debt decreased by $1.8 billion (26%) year-over-year, ending FY'25 with leverage of 4.1x, down one full turn from the previous year[26] - Free cash flow for FY'25 was $313 million, with total free cash flow including proceeds from non-core asset sales at $401 million[14] - Cash provided by operating activities for continuing operations was $438.489 million, down from $884.714 million in the previous year, reflecting operational challenges[45] - Cash, cash equivalents, and restricted cash at the end of the year stood at $431.475 million, down from $676.957 million at the beginning of the year[45] - Long-term debt reduced to $3,425.7 million in March 2025 from $4,702.3 million in March 2024[42] Operational Strategy - The company is focused on a deliberate rationalization of channel distribution to strengthen brand foundations and improve profitability[18] - The company plans to streamline operations and strengthen its balance sheet while reducing leverage as part of its ongoing transformation strategy[33] - The company plans to focus on market expansion and new product development to drive future growth, although specific details were not disclosed in the earnings call[46] Regional Performance - The Americas and EMEA regions saw revenue declines, while the APAC region remained flat, with a slight growth of 2%[24] - The Americas region revenue decreased by 6% to $995.2 million in Q4 2025[35] - EMEA revenue declined by 4% in Q4 2025 and 3% for the full year, with constant currency changes of (2%) and (3%) respectively[94] - APAC revenue remained flat at 0% in Q4 2025, with a 1% increase for the full year, and constant currency changes of 2% for both periods[94] - Greater China revenue declined by 3% in Q4 2025 but increased by 3% for the full year, with constant currency changes of (1%) and 4% respectively[94] Impairment and Charges - Impairment of goodwill and intangible assets was recorded at $89.242 million, a decrease from $507.566 million in the prior year, indicating improved asset valuation[49] - Noncash goodwill impairment charges recognized by VF amounted to $36.2 million for the three months ended March 2026 and $51.0 million for the twelve months ended March 2025[68] - The impairment charges resulted in a net tax benefit of $10.5 million for the twelve months ended March 2025[68] Shareholder Information - The company reported a basic loss per share of $0.39 for Q4 2025, compared to a loss of $1.08 in Q4 2024[39] - The adjusted diluted earnings per share for the twelve months ended March 2025 was calculated using 392,571,000 weighted average common shares[70] - VF's management believes that non-GAAP financial measures provide useful supplemental information regarding business trends and ongoing operations[71]

Financial Performance - Total revenues for Q1 2025 were RMB 7.19 billion (US$ 990.3 million), a decrease of 9% year over year[7]. - Operating income was RMB 341.9 million (US$ 47.1 million), with an operating income margin of 5%, down from 12% in Q1 2024[14]. - Non-GAAP operating income was RMB 458.5 million (US$ 63.2 million), with a non-GAAP operating income margin of 6%, compared to 14% in the same period last year[14]. - Net income attributable to iQIYI was RMB 182.1 million (US$ 25.1 million), a significant decrease from RMB 655.3 million in Q1 2024[16]. - Total revenues for the three months ended March 31, 2025, were RMB 7,186,469, a decrease of 9.4% compared to RMB 7,927,355 for the same period in 2024[35]. - Operating income for the three months ended March 31, 2025, was RMB 341,897, compared to RMB 944,753 for the same period in 2024, reflecting a decline of 63.8%[35]. - Net income attributable to iQIYI, Inc. for the three months ended March 31, 2025, was RMB 182,145, a significant recovery from a net loss of RMB 189,355 in the previous quarter[35]. - The company reported a diluted net income per ADS of RMB 0.19 for the three months ended March 31, 2025, compared to a loss of RMB 0.20 in the previous quarter[43]. - Operating income on a non-GAAP basis for the three months ended March 31, 2025, was RMB 458,535, compared to RMB 405,907 for the same period in 2024[43]. Revenue Breakdown - Membership services revenue was RMB 4.40 billion (US$ 606.2 million), down 8% year over year due to a lighter content slate[8]. - Online advertising services revenue was RMB 1.33 billion (US$ 183.0 million), decreasing 10% year over year, primarily due to a decline in brand advertising[9]. - Content distribution revenue fell to RMB 628.7 million (US$ 86.6 million), a decrease of 32% year over year[10]. - Membership services revenue increased to RMB 4,399,010, up 6.1% from RMB 4,102,688 in the previous quarter[35]. Cash Flow and Liquidity - Free cash flow for Q1 2025 was RMB 307.7 million (US$ 42.4 million), down from RMB 915.3 million in the same period last year[18]. - Free cash flow for the three months ended March 31, 2025, was RMB 307,698, down from RMB 915,344 in the same period of 2024[39]. - As of March 31, 2025, the company had cash and cash equivalents totaling RMB 5.70 billion (US$ 786.1 million)[19]. - Cash and cash equivalents at the end of the period increased to RMB 4,320,028, compared to RMB 3,590,331 at the beginning of the period[39]. Assets and Liabilities - Total assets increased to RMB 47,119,075 as of March 31, 2025, compared to RMB 45,760,525 as of December 31, 2024[37]. - Total liabilities rose to RMB 33,481,655 as of March 31, 2025, up from RMB 32,386,761 at the end of the previous quarter[37]. Debt Management - The company issued US$ 350 million of 2030 Notes in February 2025 and repurchased approximately US$ 300 million in existing notes[20].